(Q44612728)

4 December 2017

title

A conformationally frozen peptoid boosts CXCR4 affinity and anti-HIV activity (English)

1 reference

4 December 2017

5

1 reference

4 December 2017

6

1 reference

4 December 2017

Franz Hagn

3

0 references

Ruth Brack-Werner

series ordinal

7

object named as

Ruth Brack-Werner

1 reference

4 December 2017

2

Andreas O Frank

1 reference

4 December 2017

4

Margret Schottelius

1 reference

4 December 2017

1

Oliver Demmer

1 reference

4 December 2017

Stephan Kremb

8

1 reference

4 December 2017

Hans-Jürgen Wester

series ordinal

9

1 reference

4 December 2017

Horst Kessler

series ordinal

10

1 reference

4 December 2017

language of work or name

English

0 references

publication date

3 July 2012

1 reference

Angewandte Chemie International Edition

4 December 2017

published in

0 references

volume

51

1 reference

4 December 2017

issue

32

1 reference

4 December 2017

page(s)

8110-8113

1 reference

Drug discovery research targeting the CXC chemokine receptor 4 (CXCR4).

4 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201202090

The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201202090

The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201202090

CXCR4: chemokine receptor extraordinaire

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201202090

Immune and nervous system CXCL12 and CXCR4: parallel roles in patterning and plasticity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201202090

Small peptide inhibitors of the CXCR4 chemokine receptor (CD184) antagonize the activation, migration, and antiapoptotic responses of CXCL12 in chronic lymphocytic leukemia B cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201202090

HIV and the chemokine system: 10 years later

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201202090

Coreceptors and HIV-1 pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201202090

CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201202090

The therapeutic potential of CXCR4 antagonists in the treatment of HIV infection, cancer metastasis and rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201202090

Mobilization of hematopoietic stem cells: state of the art.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201202090

A low-molecular-weight inhibitor against the chemokine receptor CXCR4: a strong anti-HIV peptide T140.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201202090

Molecular mechanism of AMD3100 antagonism in the CXCR4 receptor: transfer of binding site to the CXCR3 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201202090

The AMD3100 story: the path to the discovery of a stem cell mobilizer (Mozobil).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201202090

PET imaging of CXCR4 receptors in cancer by a new optimized ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201202090

Design, synthesis, and functionalization of dimeric peptides targeting chemokine receptor CXCR4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201202090

PET of CXCR4 expression by a (68)Ga-labeled highly specific targeted contrast agent.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201202090

Molecular-size reduction of a potent CXCR4-chemokine antagonist using orthogonal combination of conformation- and sequence-based libraries

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201202090

Structure-activity relationships of cyclic peptide-based chemokine receptor CXCR4 antagonists: disclosing the importance of side-chain and backbone functionalities

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201202090

N-methylated cyclic pentaalanine peptides as template structures

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201202090

Bolaamphiphiles promote phospholipid translocation across vesicle membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201202090

A subtype-selective, use-dependent inhibitor of native AMPA receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201202090

Structures of the CXCR4 chemokine GPCR with small-molecule and cyclic peptide antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201202090

EASY-HIT: HIV full-replication technology for broad discovery of multiple classes of HIV inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201202090

Changes in growth properties on passage in tissue culture of viruses derived from infectious molecular clones of HIV-1LAI, HIV-1MAL, and HIV-1ELI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201202090

A duodenally absorbable CXC chemokine receptor 4 antagonist, KRH-1636, exhibits a potent and selective anti-HIV-1 activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201202090

Characterization of the molecular pharmacology of AMD3100: a specific antagonist of the G-protein coupled chemokine receptor, CXCR4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201202090

Synthetic therapeutic peptides: science and market

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201202090

21 January 2018

Identifiers

DOI

10.1002/ANIE.201202090

1 reference

4 December 2017

1 reference